Entrada Therapeutics, Inc. (TRDA) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $377.38M | -28.3% |
| 2024 | $526.32M | +12.2% |
| 2023 | $469.19M | +86.1% |
| 2022 | $252.06M | -17.6% |
| 2021 | $305.83M | +602.6% |
| 2020 | $43.53M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $377.38M | -28.3% |
| 2024 | $526.32M | +12.2% |
| 2023 | $469.19M | +86.1% |
| 2022 | $252.06M | -17.6% |
| 2021 | $305.83M | +602.6% |
| 2020 | $43.53M | — |